PB2056 ORBITAL LYMPHOMA: CLINICAL AND EPIDEMIOLOGICAL PATTERNS WITHIN THE UNITED STATES Article Swipe
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1097/01.hs9.0000566712.72675.cf
Background: Lymphomas are relatively common tumors that may affect the orbit through tissue infiltration. However, data available about tumors possibly originating in orbit (also called orbital lymphoma) are scarce. Aims: In this study, we aimed to spotlight on this type of malignancy using the using data from American National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program. Methods We used SEER∗Stat version 8.3.5, Microsoft Excel, as well as SPSS IBM SPSS Statistics for Windows, Version 25.0 for data analysis. In SEER∗Stat, we used the (Incidence ‐ SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2017 Sub (1973‐2015 varying)) database to obtain data. We included cases diagnosed with lymphoma between 2006 and 2015 at site related to orbital cavity C69.0‐C69.9. Results: A total of 2340 cases were identified with a median age of 65.2. Females and patients of white race represented the majority of the analyzed cohort (n = 1249, 53.4%; n = 1846, 78.9%, respectively). Age‐adjusted Incidence rate was 3 per 10,000. 5‐years observed survival was 82% (95% CI: 79.8% ‐ 84%) while the 5‐years relative survival was 94.3% (95% CI: 91.3% ‐ 96.2%). The most common pathology of studied cases was extranodal marginal zone lymphoma of mucosal‐associated lymphoid tissue (MALT) (n = 1310, 56%) [Table 1]. Median survival was not reached at the study cutoff (Figure 1). Summary/Conclusion: Orbital lymphoma has an incidence rate of 3 per 10,000. These tumors are more likely to occur in old age, females, and white race. Survival data are relatively good with the 5‐years relative survival being 94.3%. image
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1097/01.hs9.0000566712.72675.cf
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2953262789
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2953262789Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1097/01.hs9.0000566712.72675.cfDigital Object Identifier
- Title
-
PB2056 ORBITAL LYMPHOMA: CLINICAL AND EPIDEMIOLOGICAL PATTERNS WITHIN THE UNITED STATESWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-06-01Full publication date if available
- Authors
-
Mahmoud Tawfik KhalafAllah, Mohamed A. GoudaList of authors in order
- Landing page
-
https://doi.org/10.1097/01.hs9.0000566712.72675.cfPublisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1097/01.hs9.0000566712.72675.cfDirect OA link when available
- Concepts
-
Medicine, Epidemiology, Lymphoma, Incidence (geometry), Malignancy, Internal medicine, Oncology, Physics, OpticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2953262789 |
|---|---|
| doi | https://doi.org/10.1097/01.hs9.0000566712.72675.cf |
| ids.doi | https://doi.org/10.1097/01.hs9.0000566712.72675.cf |
| ids.mag | 2953262789 |
| ids.openalex | https://openalex.org/W2953262789 |
| fwci | 0.0 |
| type | article |
| title | PB2056 ORBITAL LYMPHOMA: CLINICAL AND EPIDEMIOLOGICAL PATTERNS WITHIN THE UNITED STATES |
| biblio.issue | S1 |
| biblio.volume | 3 |
| biblio.last_page | 928 |
| biblio.first_page | 928 |
| topics[0].id | https://openalex.org/T10185 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9749000072479248 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2734 |
| topics[0].subfield.display_name | Pathology and Forensic Medicine |
| topics[0].display_name | Lymphoma Diagnosis and Treatment |
| is_xpac | False |
| apc_list.value | 1200 |
| apc_list.currency | USD |
| apc_list.value_usd | 1200 |
| apc_paid.value | 1200 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 1200 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.701880931854248 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C107130276 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6951149702072144 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q133805 |
| concepts[1].display_name | Epidemiology |
| concepts[2].id | https://openalex.org/C2779338263 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5528634190559387 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q208414 |
| concepts[2].display_name | Lymphoma |
| concepts[3].id | https://openalex.org/C61511704 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5516548752784729 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1671857 |
| concepts[3].display_name | Incidence (geometry) |
| concepts[4].id | https://openalex.org/C2779399171 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5023910999298096 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1483951 |
| concepts[4].display_name | Malignancy |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.3898765742778778 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C143998085 |
| concepts[6].level | 1 |
| concepts[6].score | 0.3737093210220337 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[6].display_name | Oncology |
| concepts[7].id | https://openalex.org/C121332964 |
| concepts[7].level | 0 |
| concepts[7].score | 0.0 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[7].display_name | Physics |
| concepts[8].id | https://openalex.org/C120665830 |
| concepts[8].level | 1 |
| concepts[8].score | 0.0 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q14620 |
| concepts[8].display_name | Optics |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.701880931854248 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/epidemiology |
| keywords[1].score | 0.6951149702072144 |
| keywords[1].display_name | Epidemiology |
| keywords[2].id | https://openalex.org/keywords/lymphoma |
| keywords[2].score | 0.5528634190559387 |
| keywords[2].display_name | Lymphoma |
| keywords[3].id | https://openalex.org/keywords/incidence |
| keywords[3].score | 0.5516548752784729 |
| keywords[3].display_name | Incidence (geometry) |
| keywords[4].id | https://openalex.org/keywords/malignancy |
| keywords[4].score | 0.5023910999298096 |
| keywords[4].display_name | Malignancy |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.3898765742778778 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/oncology |
| keywords[6].score | 0.3737093210220337 |
| keywords[6].display_name | Oncology |
| language | en |
| locations[0].id | doi:10.1097/01.hs9.0000566712.72675.cf |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210211592 |
| locations[0].source.issn | 2572-9241 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2572-9241 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | HemaSphere |
| locations[0].source.host_organization | https://openalex.org/P4310318547 |
| locations[0].source.host_organization_name | Wolters Kluwer |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310318547 |
| locations[0].source.host_organization_lineage_names | Wolters Kluwer |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | HemaSphere |
| locations[0].landing_page_url | https://doi.org/10.1097/01.hs9.0000566712.72675.cf |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5023923800 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-7973-5883 |
| authorships[0].author.display_name | Mahmoud Tawfik KhalafAllah |
| authorships[0].countries | EG |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I63601056 |
| authorships[0].affiliations[0].raw_affiliation_string | Menoufia Faculty of Medicine, Shebin ElKom, Egypt |
| authorships[0].institutions[0].id | https://openalex.org/I63601056 |
| authorships[0].institutions[0].ror | https://ror.org/05sjrb944 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I63601056 |
| authorships[0].institutions[0].country_code | EG |
| authorships[0].institutions[0].display_name | Menoufia University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | M. khalafAllah |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Menoufia Faculty of Medicine, Shebin ElKom, Egypt |
| authorships[1].author.id | https://openalex.org/A5071742593 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-4829-6739 |
| authorships[1].author.display_name | Mohamed A. Gouda |
| authorships[1].countries | EG |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I63601056 |
| authorships[1].affiliations[0].raw_affiliation_string | Menoufia Faculty of Medicine, Shebin ElKom, Egypt |
| authorships[1].institutions[0].id | https://openalex.org/I63601056 |
| authorships[1].institutions[0].ror | https://ror.org/05sjrb944 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I63601056 |
| authorships[1].institutions[0].country_code | EG |
| authorships[1].institutions[0].display_name | Menoufia University |
| authorships[1].author_position | last |
| authorships[1].raw_author_name | M. gouda |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Menoufia Faculty of Medicine, Shebin ElKom, Egypt |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1097/01.hs9.0000566712.72675.cf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | PB2056 ORBITAL LYMPHOMA: CLINICAL AND EPIDEMIOLOGICAL PATTERNS WITHIN THE UNITED STATES |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10185 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9749000072479248 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2734 |
| primary_topic.subfield.display_name | Pathology and Forensic Medicine |
| primary_topic.display_name | Lymphoma Diagnosis and Treatment |
| related_works | https://openalex.org/W2092561569, https://openalex.org/W2377100155, https://openalex.org/W599478544, https://openalex.org/W1576711507, https://openalex.org/W647896512, https://openalex.org/W3121757313, https://openalex.org/W4231462739, https://openalex.org/W562084794, https://openalex.org/W2793887421, https://openalex.org/W2408973000 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1097/01.hs9.0000566712.72675.cf |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210211592 |
| best_oa_location.source.issn | 2572-9241 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2572-9241 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | HemaSphere |
| best_oa_location.source.host_organization | https://openalex.org/P4310318547 |
| best_oa_location.source.host_organization_name | Wolters Kluwer |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310318547 |
| best_oa_location.source.host_organization_lineage_names | Wolters Kluwer |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | HemaSphere |
| best_oa_location.landing_page_url | https://doi.org/10.1097/01.hs9.0000566712.72675.cf |
| primary_location.id | doi:10.1097/01.hs9.0000566712.72675.cf |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210211592 |
| primary_location.source.issn | 2572-9241 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2572-9241 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | HemaSphere |
| primary_location.source.host_organization | https://openalex.org/P4310318547 |
| primary_location.source.host_organization_name | Wolters Kluwer |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310318547 |
| primary_location.source.host_organization_lineage_names | Wolters Kluwer |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | HemaSphere |
| primary_location.landing_page_url | https://doi.org/10.1097/01.hs9.0000566712.72675.cf |
| publication_date | 2019-06-01 |
| publication_year | 2019 |
| referenced_works_count | 0 |
| abstract_inverted_index.+ | 92 |
| abstract_inverted_index.3 | 164, 231 |
| abstract_inverted_index.= | 152, 156, 207 |
| abstract_inverted_index.A | 125 |
| abstract_inverted_index.a | 133 |
| abstract_inverted_index.n | 155 |
| abstract_inverted_index.(n | 151, 206 |
| abstract_inverted_index.18 | 88 |
| abstract_inverted_index.In | 30, 80 |
| abstract_inverted_index.We | 59, 107 |
| abstract_inverted_index.an | 227 |
| abstract_inverted_index.as | 66, 68 |
| abstract_inverted_index.at | 117, 217 |
| abstract_inverted_index.in | 21, 241 |
| abstract_inverted_index.of | 40, 127, 136, 141, 147, 193, 201, 230 |
| abstract_inverted_index.on | 37 |
| abstract_inverted_index.to | 35, 104, 120, 239 |
| abstract_inverted_index.we | 33, 82 |
| abstract_inverted_index.1). | 222 |
| abstract_inverted_index.1]. | 211 |
| abstract_inverted_index.82% | 171 |
| abstract_inverted_index.CI: | 173, 185 |
| abstract_inverted_index.End | 54 |
| abstract_inverted_index.IBM | 70 |
| abstract_inverted_index.Nov | 98 |
| abstract_inverted_index.Sub | 100 |
| abstract_inverted_index.The | 189 |
| abstract_inverted_index.age | 135 |
| abstract_inverted_index.and | 53, 115, 139, 245 |
| abstract_inverted_index.are | 2, 27, 236, 250 |
| abstract_inverted_index.for | 73, 77 |
| abstract_inverted_index.has | 226 |
| abstract_inverted_index.may | 7 |
| abstract_inverted_index.not | 215 |
| abstract_inverted_index.old | 242 |
| abstract_inverted_index.per | 165, 232 |
| abstract_inverted_index.the | 9, 43, 84, 145, 148, 178, 218, 254 |
| abstract_inverted_index.was | 163, 170, 182, 196, 214 |
| abstract_inverted_index.‐ | 86, 175, 187 |
| abstract_inverted_index.(95% | 172, 184 |
| abstract_inverted_index.2006 | 114 |
| abstract_inverted_index.2015 | 116 |
| abstract_inverted_index.2017 | 99 |
| abstract_inverted_index.2340 | 128 |
| abstract_inverted_index.25.0 | 76 |
| abstract_inverted_index.56%) | 209 |
| abstract_inverted_index.84%) | 176 |
| abstract_inverted_index.Data | 91 |
| abstract_inverted_index.Regs | 89 |
| abstract_inverted_index.SEER | 87 |
| abstract_inverted_index.SPSS | 69, 71 |
| abstract_inverted_index.age, | 243 |
| abstract_inverted_index.data | 15, 45, 78, 249 |
| abstract_inverted_index.from | 46 |
| abstract_inverted_index.good | 252 |
| abstract_inverted_index.more | 237 |
| abstract_inverted_index.most | 190 |
| abstract_inverted_index.race | 143 |
| abstract_inverted_index.rate | 162, 229 |
| abstract_inverted_index.site | 118 |
| abstract_inverted_index.that | 6 |
| abstract_inverted_index.this | 31, 38 |
| abstract_inverted_index.type | 39 |
| abstract_inverted_index.used | 60, 83 |
| abstract_inverted_index.well | 67 |
| abstract_inverted_index.were | 130 |
| abstract_inverted_index.with | 111, 132, 253 |
| abstract_inverted_index.zone | 199 |
| abstract_inverted_index.(also | 23 |
| abstract_inverted_index.1249, | 153 |
| abstract_inverted_index.1310, | 208 |
| abstract_inverted_index.1846, | 157 |
| abstract_inverted_index.65.2. | 137 |
| abstract_inverted_index.79.8% | 174 |
| abstract_inverted_index.91.3% | 186 |
| abstract_inverted_index.94.3% | 183 |
| abstract_inverted_index.Aims: | 29 |
| abstract_inverted_index.These | 234 |
| abstract_inverted_index.about | 17 |
| abstract_inverted_index.aimed | 34 |
| abstract_inverted_index.being | 258 |
| abstract_inverted_index.cases | 109, 129, 195 |
| abstract_inverted_index.data. | 106 |
| abstract_inverted_index.image | 260 |
| abstract_inverted_index.occur | 240 |
| abstract_inverted_index.orbit | 10, 22 |
| abstract_inverted_index.race. | 247 |
| abstract_inverted_index.study | 219 |
| abstract_inverted_index.total | 126 |
| abstract_inverted_index.using | 42, 44 |
| abstract_inverted_index.while | 177 |
| abstract_inverted_index.white | 142, 246 |
| abstract_inverted_index.(MALT) | 205 |
| abstract_inverted_index.(SEER) | 56 |
| abstract_inverted_index.53.4%; | 154 |
| abstract_inverted_index.78.9%, | 158 |
| abstract_inverted_index.8.3.5, | 63 |
| abstract_inverted_index.94.3%. | 259 |
| abstract_inverted_index.Cancer | 49 |
| abstract_inverted_index.Cases, | 97 |
| abstract_inverted_index.Excel, | 65 |
| abstract_inverted_index.Median | 212 |
| abstract_inverted_index.[Table | 210 |
| abstract_inverted_index.affect | 8 |
| abstract_inverted_index.called | 24 |
| abstract_inverted_index.cavity | 122 |
| abstract_inverted_index.cohort | 150 |
| abstract_inverted_index.common | 4, 191 |
| abstract_inverted_index.cutoff | 220 |
| abstract_inverted_index.likely | 238 |
| abstract_inverted_index.median | 134 |
| abstract_inverted_index.obtain | 105 |
| abstract_inverted_index.study, | 32 |
| abstract_inverted_index.tissue | 12, 204 |
| abstract_inverted_index.tumors | 5, 18, 235 |
| abstract_inverted_index.(Figure | 221 |
| abstract_inverted_index.10,000. | 166, 233 |
| abstract_inverted_index.96.2%). | 188 |
| abstract_inverted_index.Females | 138 |
| abstract_inverted_index.Katrina | 94 |
| abstract_inverted_index.Methods | 58 |
| abstract_inverted_index.Orbital | 224 |
| abstract_inverted_index.Results | 55 |
| abstract_inverted_index.Version | 75 |
| abstract_inverted_index.between | 113 |
| abstract_inverted_index.orbital | 25, 121 |
| abstract_inverted_index.reached | 216 |
| abstract_inverted_index.related | 119 |
| abstract_inverted_index.scarce. | 28 |
| abstract_inverted_index.studied | 194 |
| abstract_inverted_index.through | 11 |
| abstract_inverted_index.version | 62 |
| abstract_inverted_index.American | 47 |
| abstract_inverted_index.However, | 14 |
| abstract_inverted_index.Impacted | 95 |
| abstract_inverted_index.National | 48 |
| abstract_inverted_index.Program. | 57 |
| abstract_inverted_index.Research | 90 |
| abstract_inverted_index.Results: | 124 |
| abstract_inverted_index.Survival | 248 |
| abstract_inverted_index.Windows, | 74 |
| abstract_inverted_index.analyzed | 149 |
| abstract_inverted_index.database | 103 |
| abstract_inverted_index.females, | 244 |
| abstract_inverted_index.included | 108 |
| abstract_inverted_index.lymphoid | 203 |
| abstract_inverted_index.lymphoma | 112, 200, 225 |
| abstract_inverted_index.majority | 146 |
| abstract_inverted_index.marginal | 198 |
| abstract_inverted_index.observed | 168 |
| abstract_inverted_index.patients | 140 |
| abstract_inverted_index.possibly | 19 |
| abstract_inverted_index.relative | 180, 256 |
| abstract_inverted_index.survival | 169, 181, 213, 257 |
| abstract_inverted_index.5‐years | 167, 179, 255 |
| abstract_inverted_index.Hurricane | 93 |
| abstract_inverted_index.Incidence | 161 |
| abstract_inverted_index.Louisiana | 96 |
| abstract_inverted_index.Lymphomas | 1 |
| abstract_inverted_index.Microsoft | 64 |
| abstract_inverted_index.analysis. | 79 |
| abstract_inverted_index.available | 16 |
| abstract_inverted_index.diagnosed | 110 |
| abstract_inverted_index.incidence | 228 |
| abstract_inverted_index.lymphoma) | 26 |
| abstract_inverted_index.pathology | 192 |
| abstract_inverted_index.spotlight | 36 |
| abstract_inverted_index.varying)) | 102 |
| abstract_inverted_index.(Incidence | 85 |
| abstract_inverted_index.Institute, | 50 |
| abstract_inverted_index.Statistics | 72 |
| abstract_inverted_index.extranodal | 197 |
| abstract_inverted_index.identified | 131 |
| abstract_inverted_index.malignancy | 41 |
| abstract_inverted_index.relatively | 3, 251 |
| abstract_inverted_index.Background: | 0 |
| abstract_inverted_index.SEER∗Stat | 61 |
| abstract_inverted_index.originating | 20 |
| abstract_inverted_index.represented | 144 |
| abstract_inverted_index.(1973‐2015 | 101 |
| abstract_inverted_index.SEER∗Stat, | 81 |
| abstract_inverted_index.Epidemiology, | 52 |
| abstract_inverted_index.Surveillance, | 51 |
| abstract_inverted_index.infiltration. | 13 |
| abstract_inverted_index.Age‐adjusted | 160 |
| abstract_inverted_index.C69.0‐C69.9. | 123 |
| abstract_inverted_index.respectively). | 159 |
| abstract_inverted_index.Summary/Conclusion: | 223 |
| abstract_inverted_index.mucosal‐associated | 202 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 2 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8600000143051147 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.09572614 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |